Vertex Adds Pain Medication to 340B Contract Pharmacy Restrictions

Vertex announced on Feb. 4 that its contract pharmacy restrictions policy would immediately apply to Journavx.
A Boston-based drugmaker recently added a newly approved non-opiate pain treatment to the list of drugs subject to its 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Dark Money Group Gave Anti-340B PAC Nearly $5M in 2024, Influential PR Firm Raked in Over $300,000

Stand for US PAC reported receiving a total of more than $4.8 million from Building America's Future, a Washington, D.C.-based 501(c)(4) nonprofit that does not disclose its donors, in 2024.
Building America’s Future (BAF), a powerful conservative dark money group with ties to the Trump administration, contributed almost $5 million [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Committee Confirms RFK Jr.’s HHS Secretary Nomination by 14-13 Vote with Cassidy’s Support

The Senate Finance Committee voted 14-13 on Tuesday to confirm Robert F. Kennedy Jr. as Health and Human Services (HHS) secretary.
A key Senate panel voted today to confirm Robert F. Kennedy Jr. as President Donald Trump’s (R) controversial pick to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Big Mergers and Acquisitions in the 340B Service Industry Announced

Skip Devanny, the longtime RxStrategies CEO has been named CEO of the newly branded and larger company Pillr Health. Meanwhile, Nuvem CEO Scott Seidelmann touted his company's acquisition of 340B pharmacy analytics provider Louvir.
Several major 340B service companies announced mergers and acquisitions this week that officials said will expand their offerings and resources [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

HELP Committee Questions RFK Jr. on Drug Pricing, Medicare and Medicaid but Not 340B 

HHS Secretary nominee Robert F. Kennedy Jr. appeared before the the Senate Health, Education, Labor and Pensions Committee on Thursday.
Robert F. Kennedy Jr., President Donald Trump’s pick to lead the U.S. Department of Health and Human Services (HHS), fielded [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

RFK Jr. Backs PBM, Drug Pricing Reform at Senate Confirmation Hearing, 340B Not Discussed but Could Come Up Today

HHS Secretary nominee Robert F. Kennedy Jr. offered support for pharmacy benefit manager and prescription drug pricing reform, but did not comment specifically on the 340B program during his Senate Finance Committee confirmation hearing on Wednesday.
Robert F. Kennedy Jr., President Donald Trump’s (R) Health and Human Services (HHS) secretary nominee, offered support for pharmacy benefit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump Administration Signals Support for IRA Drug Price Negotiations

The Centers for Medicare and Medicaid Services signaled in a Wednesday statement that it will continue the Inflation Reduction Act’s Medicare Part D drug price negotiations.
The Trump Administration indicated Wednesday that it will continue the Inflation Reduction Act’s (IRA) Medicare drug price negotiations, a signature [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GOP Eyes 340B Commercial Pay Rate Cut, Advocates Slam Reconciliation Proposal

The House's budget options “menu" includes a proposal to prohibit 340B covered entities from charging employer-sponsored commercial insurance plans full price for 340B discounted drugs.
Congressional Republicans are considering a contentious proposal that would prohibit 340B covered entities from charging employer-sponsored commercial insurance plans full [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

5 Questions to Assess the Effectiveness of Your 340B Pharmacy Program and Position it to Optimize Outcomes

SPONSORED CONTENT

Successful

Read More »

Exclusive

Dr. Oz, Trump’s Pick to Lead CMS, Linked to Senior Role in Company that Partners With 340B Hospitals

ZorroRx listed Mehmet Oz, President Donald Trump's nominee to lead CMS, as its chief strategy officer and part of its “founding team” in a presentation shared with 340B Report.
Mehmet Oz, the celebrity heart surgeon and former U.S. Senate candidate that President Donald Trump nominated to lead the Centers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live